Basic Information
Amagma Therapeutics Develops Novel Antibody Therapies Targeting Dysfunctional Diseases Caused by Essential Proteases and Other Enzymes.
Amagma Therapeutics
Massachusetts,United States of America
15~50 people
January 01, 2019
--